Where are They Now? C2E2 Alumni Lisa Masucci tells her story
Lisa Masucci completed a Master of Science in Health Services Research from the Institute of Health Policy, Management and Evaluation at the University of Toronto and is currently pursuing a PhD in Health Technology Assessment. Lisa has worked in both research and government settings. She currently works full-time as a Health Economist at St. Michael’s Hospital conducting cost-effectiveness and budget impact analyses on a wide variety of technologies and interventions. Lisa has worked on the cost-effectiveness of technologies from a variety of fields of medicine including oncology, endocrinology, urology, psychiatry, and gastroenterology.
Lisa’s primary research interests include methods for the assessment of health technologies and decision analytic modelling. Her PhD thesis will focus on the cost-effectiveness of regenerative medicines, which have high cost, early evidence of effectiveness, treatment uncertainty, and the potential to cure a patient. In addition to constructing a decision analytic model to examine the cost-effectiveness she will be conducting a value of information analysis to look at the benefit of collecting more evidence and a headroom analysis to assess the maximum potential value of an innovation.
Lisa joined C2E2 as a Health Economics Research Coordinator. While at C2E2, Lisa worked on a number of different projects assessing the cost-effectiveness of technologies, conducting literature reviews, and assisting with health care priority setting activities. For one of her main projects, Lisa built a Markov Model to assess the cost-effectiveness of a stool color card for a rare paediatric liver disease. She has presented this research at national and international conferences as well as published her findings in the Journal of Medicine Screening.
Click here for more information about Lisa’s research and publications.
C2E2 Rounds are presented Mondays from 12:00 pm to 1:00 pm in room 700 of the VGH Research Pavilion, 828 West 10th Avenue, Vancouver, BC.
Jun 13, 2022 // Boris Sobolev